Last update 20 Mar 2025

Allogeneic CAR-T (National University Hospital)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [4]
Active Indication
acute leukemiaB lymphoblastic leukemia lymphomaCarney Complex+ [1]
Inactive Indication-
Originator Organization
National University HospitalNational University Hospital
Active Organization
National University HospitalNational University Hospital
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Allogeneic CAR-T (National University Hospital)
NCT05038696
/ RecruitingPhase 1IIT
Chimeric-Antigen Receptor (CAR) T-Cell Therapy Using Multiple CARs and Cell Marker Profiling in High Risk and Relapsed/ Refractory B-Lineage Acute Lymphoblastic Leukaemia
100 Clinical Results associated with Allogeneic CAR-T (National University Hospital)
Login to view more data
100 Translational Medicine associated with Allogeneic CAR-T (National University Hospital)
Login to view more data
100 Patents (Medical) associated with Allogeneic CAR-T (National University Hospital)
Login to view more data
1
Literatures (Medical) associated with Allogeneic CAR-T (National University Hospital)
Chinese Medical Journal
Toxic epidermal necrosis caused by programmed cell death protein 1 inhibitors in a patient receiving chimeric antigen receptor-T cell therapy
100 Deals associated with Allogeneic CAR-T (National University Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
acute leukemiaPhase 1
Singapore
National University HospitalNational University Hospital
28 Apr 2021
B lymphoblastic leukemia lymphomaPhase 1
Singapore
National University HospitalNational University Hospital
28 Apr 2021
Carney ComplexPhase 1
Singapore
National University HospitalNational University Hospital
28 Apr 2021
Refractory B Acute Lymphoblastic LeukemiaPhase 1
Singapore
National University HospitalNational University Hospital
28 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free